All Phenotypes Mtdh<Gt(XB780)Byg> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Mtdh^Gt(XB780)Byg
gene trap XB780, BayGenomics
MGI:4124379

Summary

6 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Mtdh^Gt(XB780)Byg/Mtdh^Gt(XB780)Byg	FVB.129P2-Mtdh^Gt(XB780)Byg	MGI:5649037
cx2	Mtdh^Gt(XB780)Byg/Mtdh^Gt(XB780)Byg Tg(MMTVneu)202Mul/0	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(MMTVneu)202Mul	MGI:5661728
cx3	Mtdh^Gt(XB780)Byg/Mtdh^Gt(XB780)Byg Tg(MMTV-PyVT)634Mul/0	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(MMTV-PyVT)634Mul	MGI:5649039
cx4	Mtdh^Gt(XB780)Byg/Mtdh⁺ Tg(MMTV-PyVT)634Mul/0	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(MMTV-PyVT)634Mul	MGI:5649043
cx5	Mtdh^Gt(XB780)Byg/Mtdh^Gt(XB780)Byg Tg(Wnt1)1Hev/0	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(Wnt1)1Hev	MGI:5649041
cx6	Mtdh^Gt(XB780)Byg/Mtdh⁺ Tg(Wnt1)1Hev/0	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(Wnt1)1Hev	MGI:5649042

Allelic Composition	Mtdh^Gt(XB780)Byg/Mtdh^Gt(XB780)Byg
Genetic Background	FVB.129P2-Mtdh^Gt(XB780)Byg

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mtdh^Gt(XB780)Byg mutation (0 available); any Mtdh mutation (32 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

decreased susceptibility to xenobiotic induced morbidity/mortality ( J:214244 )

• increased time of tumor free survival following treatment with medroxyprogesterone acetate (MPA) and 7, 12-dimethylbenzanthracene (DMBA)

neoplasm

decreased incidence of tumors by chemical induction ( J:214244 )

• decreased mammary tumor incidence following treatment with medroxyprogesterone acetate (MPA) and 7, 12-dimethylbenzanthracene (DMBA)

endocrine/exocrine glands

abnormal branching of the mammary ductal tree ( J:214244 )

• transient delay in ductal outgrowth from 3 to 5 weeks of age

• however, no significant differences are detected at later time points or during pregnancy and lactation

reproductive system

reproductive system phenotype ( J:214244 )

• fertile

homeostasis/metabolism

decreased susceptibility to xenobiotic induced morbidity/mortality ( J:214244 )

• increased time of tumor free survival following treatment with medroxyprogesterone acetate (MPA) and 7, 12-dimethylbenzanthracene (DMBA)

decreased incidence of tumors by chemical induction ( J:214244 )

• decreased mammary tumor incidence following treatment with medroxyprogesterone acetate (MPA) and 7, 12-dimethylbenzanthracene (DMBA)

integument

abnormal branching of the mammary ductal tree ( J:214244 )

• transient delay in ductal outgrowth from 3 to 5 weeks of age

• however, no significant differences are detected at later time points or during pregnancy and lactation

Allelic Composition	Mtdh^Gt(XB780)Byg/Mtdh^Gt(XB780)Byg Tg(MMTVneu)202Mul/0
Genetic Background	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(MMTVneu)202Mul

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mtdh^Gt(XB780)Byg mutation (0 available); any Mtdh mutation (32 available)
Tg(MMTVneu)202Mul mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

decreased mammary gland tumor incidence ( J:214244 )

• by 300 days of age only 60% of mice develop tumors while almost all transgenic mice wild-type for Mtdh have tumors by this age

• by 18 months of age, 30% of mice are tumor free

decreased metastatic potential ( J:214244 )

• lung metastasis are severely reduced

increased tumor latency ( J:214244 )

• by 300 days of age only 60% of mice develop tumors while almost all transgenic mice wild-type for Mtdh have tumors by this age

• by 18 months of age, 30% of mice are tumor free

integument

decreased mammary gland tumor incidence ( J:214244 )

• by 300 days of age only 60% of mice develop tumors while almost all transgenic mice wild-type for Mtdh have tumors by this age

• by 18 months of age, 30% of mice are tumor free

mammary gland hyperplasia ( J:214244 )

• only 20% of mice are mildly hyperplastic while 100% of transgenic mice wild-type for Mtdh display hyperplasia at 6 months of age

endocrine/exocrine glands

decreased mammary gland tumor incidence ( J:214244 )

• by 300 days of age only 60% of mice develop tumors while almost all transgenic mice wild-type for Mtdh have tumors by this age

• by 18 months of age, 30% of mice are tumor free

mammary gland hyperplasia ( J:214244 )

• only 20% of mice are mildly hyperplastic while 100% of transgenic mice wild-type for Mtdh display hyperplasia at 6 months of age

Allelic Composition	Mtdh^Gt(XB780)Byg/Mtdh^Gt(XB780)Byg Tg(MMTV-PyVT)634Mul/0
Genetic Background	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(MMTV-PyVT)634Mul

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mtdh^Gt(XB780)Byg mutation (0 available); any Mtdh mutation (32 available)
Tg(MMTV-PyVT)634Mul mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

decreased mammary gland tumor incidence ( J:214244 )

• total tumor burden is reduced to 10% of transgenic mice wild-type for Mtdh

abnormal tumor pathology ( J:214244 )

• isolated mammary epithelial cells from preneoplastic glands contain fewer tumor initiating cells

decreased metastatic potential ( J:214244 )

• mice have fewer and smaller metastatic nodules compared to transgenic mice wild-type for Mtdh

increased tumor latency ( J:214244 )

• mammary tumors are detected by 50 days of age and 50% of mice have tumors after 80 days of age, later than in transgenic mice wild-type for Mtdh

endocrine/exocrine glands

decreased mammary gland tumor incidence ( J:214244 )

• total tumor burden is reduced to 10% of transgenic mice wild-type for Mtdh

mammary gland hyperplasia ( J:214244 )

• display fewer and smaller hyperplastic foci at 4 weeks of age compared to transgenic mice wild-type for Mtdh

integument

decreased mammary gland tumor incidence ( J:214244 )

• total tumor burden is reduced to 10% of transgenic mice wild-type for Mtdh

mammary gland hyperplasia ( J:214244 )

• display fewer and smaller hyperplastic foci at 4 weeks of age compared to transgenic mice wild-type for Mtdh

Allelic Composition	Mtdh^Gt(XB780)Byg/Mtdh⁺ Tg(MMTV-PyVT)634Mul/0
Genetic Background	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(MMTV-PyVT)634Mul

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mtdh^Gt(XB780)Byg mutation (0 available); any Mtdh mutation (32 available)
Tg(MMTV-PyVT)634Mul mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

decreased mammary gland tumor incidence ( J:214244 )

• total tumor burden is reduced to 54% of transgenic mice wild-type for Mtdh

integument

decreased mammary gland tumor incidence ( J:214244 )

• total tumor burden is reduced to 54% of transgenic mice wild-type for Mtdh

endocrine/exocrine glands

decreased mammary gland tumor incidence ( J:214244 )

• total tumor burden is reduced to 54% of transgenic mice wild-type for Mtdh

Allelic Composition	Mtdh^Gt(XB780)Byg/Mtdh^Gt(XB780)Byg Tg(Wnt1)1Hev/0
Genetic Background	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(Wnt1)1Hev

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mtdh^Gt(XB780)Byg mutation (0 available); any Mtdh mutation (32 available)
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

decreased mammary gland tumor incidence ( J:214244 )

• no tumors are detected in 62% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

• the number of tumors in mice with tumors is also reduced compared to transgenic mice wild-type for Mtdh

increased tumor latency ( J:214244 )

• no tumors are detected in 62% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

integument

decreased mammary gland tumor incidence ( J:214244 )

• no tumors are detected in 62% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

• the number of tumors in mice with tumors is also reduced compared to transgenic mice wild-type for Mtdh

mammary gland hyperplasia ( J:214244 )

• display fewer and smaller hyperplastic foci at 4 weeks of age compared to transgenic mice wild-type for Mtdh

endocrine/exocrine glands

decreased mammary gland tumor incidence ( J:214244 )

• no tumors are detected in 62% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

• the number of tumors in mice with tumors is also reduced compared to transgenic mice wild-type for Mtdh

mammary gland hyperplasia ( J:214244 )

• display fewer and smaller hyperplastic foci at 4 weeks of age compared to transgenic mice wild-type for Mtdh

Allelic Composition	Mtdh^Gt(XB780)Byg/Mtdh⁺ Tg(Wnt1)1Hev/0
Genetic Background	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(Wnt1)1Hev

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mtdh^Gt(XB780)Byg mutation (0 available); any Mtdh mutation (32 available)
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

decreased mammary gland tumor incidence ( J:214244 )

• no tumors are detected in 35% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

• the number of tumors in mice with tumors is also reduced compared to transgenic mice wild-type for Mtdh

increased tumor latency ( J:214244 )

• no tumors are detected in 35% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

endocrine/exocrine glands

decreased mammary gland tumor incidence ( J:214244 )

• no tumors are detected in 35% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

• the number of tumors in mice with tumors is also reduced compared to transgenic mice wild-type for Mtdh

integument

decreased mammary gland tumor incidence ( J:214244 )

• no tumors are detected in 35% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

• the number of tumors in mice with tumors is also reduced compared to transgenic mice wild-type for Mtdh

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 05/07/2024 MGI 6.23